EDGAR Filing Documents for 0001171843-15-006825

Form 8-K - Current report:

SEC Accession No. 0001171843-15-006825

Filing Date

2015-12-15

Accepted

2015-12-15 16:15:10

Documents

Period of Report

2015-12-11

Items

Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	gff8k_121415.htm	8-K	23765
2	EXHIBIT 10.1	exh_101.htm	EX-10.1	108331
3	EXHIBIT 10.2	exh_102.htm	EX-10.2	13696
4	EXHIBIT 10.3	exh_103.htm	EX-10.3	13744
5	EXHIBIT 10.4	exh_104.htm	EX-10.4	13615
6	EXHIBIT 10.5	exh_105.htm	EX-10.5	13711
7	EXHIBIT 10.6	exh_106.htm	EX-10.6	12714
8	EXHIBIT 99.1	exh_991.htm	EX-99.1	9926
9	GRAPHIC	logo.jpg	GRAPHIC	47485
	Complete submission text file	0001171843-15-006825.txt		276379

Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281

Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520

Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)